Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial (Q30398420)

21 June 2017

title

Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial (English)

1 reference

21 June 2017

0 references

0 references

placebo-controlled trial

1 reference

Eric Plennevaux

1

1 reference

21 June 2017

Mark Blatter

2

1 reference

21 June 2017

Matthew J Cornish

3

1 reference

21 June 2017

Kerry Go

4

1 reference

21 June 2017

Daniel Kirby

5

1 reference

21 June 2017

Mostafa Wali

6

1 reference

21 June 2017

Mary-Kate Reeves-Hoché

7

1 reference

21 June 2017

Martine Denis

8

1 reference

21 June 2017

language of work or name

English

0 references

publication date

8 January 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

8

1 reference

21 June 2017

page(s)

1569-1575

1 reference

Australia's winter with the 2009 pandemic influenza A (H1N1) virus.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

A novel influenza A (H1N1) vaccine in various age groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

The safety and immunogenicity of influenza vaccine in children with asthma in Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.116

10.1016/J.VACCINE.2010.12.116

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference